Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

US10434077B2 · kind B2 · utility

Assignee

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

• Teymuras Kurzchalia · Berlin, DE
• Anthony Hyman · Dresden, DE
• Yusuke Toyoda · Dresden, DE
• Francisco Pan-Montojo · Dresden, DE
• Cihan Erkut · Dresden, DE

Key dates

• Filing date: Mar 31, 2015
• Grant date: Oct 8, 2019
• Expiry date: Mar 4, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A23V2002/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treatment of a neurodegenerative disease which is associated with a decline in mitochondrial activity, includes administering to a person in need of such treatment at least one of Glycolic acid or a pharmaceutically acceptable salt or ester thereof, and D-lactic acid or a pharmaceutically acceptable salt or ester thereof.